Find trials
Search tips

Detection of Reduced Left Ventricular Ejection Fraction with Single Lead ECG Using Artificial Intelligence

Overview

About this study

The purpose of this study is to modify and adapt the algorithm to be usable in a mobile form factor with a limited number of leads. For this, will prospectively test and validate the adapted algorithm in outpatients presenting to the echocardiography laboratory and to test the sensitivity and specificity of a single lead ECG to identify people with decreased left ventricular EF.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults 18 years and older
  • English Speaking
  • Able to Provide informed consent

Exclusion Criteria: 

  • Barriers to providing informed consent
  • Hospitalized patients
  • Patients with infiltrative cardiomyopathies, cardiac transplant, hypertrophic cardiomyopathy, and a history of prosthetic heart valves

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Paul Friedman, M.D.

Closed for enrollment

Contact information:

Jennifer Dugan

(507) 538-1125

Dugan.Jennifer@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20420887

Mayo Clinic Footer